HuGE Literature Finder
Records
1
-
7
Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study. Turkish journal of haematology : official journal of Turkish Society of Haematology 2019 Jul . Varbanova Viktoria Plamenova, Mihailova Snejina, Naumova Elissaveta, Mihaylova Anastasiya Petro |
Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians. Human immunology 2015 Oct . Misra Maneesh Kumar, Prakash Swayam, Moulik Nirmalya Roy, Kumar Archana, Agrawal Suraks |
Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients. Experimental hematology 2015 Aug . Caocci Giovanni, Martino Bruno, Greco Marianna, Abruzzese Elisabetta, Trawinska Malgorzata Monika, Lai Sara, Ragatzu Paola, Galimberti Sara, Baratè Claudia, Mulas Olga, Labate Claudia, Littera Roberto, Carcassi Carlo, Passerini Carlo Gambacorti, La Nasa Giorg |
Comparison of the KIR3DS1/Bw4 distribution in Chinese healthy and acute myeloid leukemia individuals. Human immunology 2015 Mar 76 (2-3): 79-82. Tao Sudan, He Yanmin, Zhang Wei, Wang Wei, He Junjun, Han Zhedong, Chen Nanying, Dong Lina, He Ji, Zhu Faming, Lv Hangj |
In contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infection. Human immunology 2012 Aug 73 (8): 783-7. O'Connor Geraldine M, Seich Al Basatena Nafisa-Katrin, Olavarria Viviana, MacNamara Aidan, Vine Alison, Ying Qi, Hisada Michie, Galvão-Castro Bernardo, Asquith Becca, McVicar Daniel |
KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease. Tissue antigens 2011 Aug 78 (2): 129-38. Karabon L, Jedynak A, Giebel S, Wo?owiec D, Kielbinski M, Woszczyk D, Kapelko-Slowik K, Kuliczkowski K, Frydecka |
Excess of activating killer cell immunoglobulin-like receptors and lack of HLA-Bw4 ligands: a two-edged weapon in chronic fatigue syndrome. Molecular medicine reports 2011 May 4 (3): 3. Pasi A, Bozzini S, Carlo-Stella N, Martinetti M, Bombardieri S, De Silvestri A, Salvaneschi L, Cuccia M |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: